Investors Asset Management of Georgia Inc. GA ADV Has $674,000 Holdings in CVS Health Co. (NYSE:CVS)

Investors Asset Management of Georgia Inc. GA ADV lifted its position in shares of CVS Health Co. (NYSE:CVS) by 6.0% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,721 shares of the pharmacy operator’s stock after purchasing an additional 609 shares during the quarter. Investors Asset Management of Georgia Inc. GA ADV’s holdings in CVS Health were worth $674,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Greenwich Wealth Management LLC lifted its stake in shares of CVS Health by 3.9% in the third quarter. Greenwich Wealth Management LLC now owns 24,557 shares of the pharmacy operator’s stock valued at $1,544,000 after buying an additional 922 shares in the last quarter. Chicago Partners Investment Group LLC lifted its position in CVS Health by 5.2% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 13,620 shares of the pharmacy operator’s stock valued at $856,000 after acquiring an additional 676 shares in the last quarter. Weatherly Asset Management L. P. boosted its stake in CVS Health by 12.4% during the 3rd quarter. Weatherly Asset Management L. P. now owns 15,426 shares of the pharmacy operator’s stock valued at $970,000 after purchasing an additional 1,699 shares during the last quarter. Capital Advisors Inc. OK raised its stake in shares of CVS Health by 1.7% in the third quarter. Capital Advisors Inc. OK now owns 15,711 shares of the pharmacy operator’s stock worth $988,000 after purchasing an additional 261 shares during the last quarter. Finally, Gladstone Institutional Advisory LLC boosted its position in shares of CVS Health by 24.2% during the third quarter. Gladstone Institutional Advisory LLC now owns 14,556 shares of the pharmacy operator’s stock valued at $915,000 after buying an additional 2,832 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Performance

Shares of NYSE:CVS traded down $0.65 during midday trading on Friday, reaching $55.81. 13,581,795 shares of the company traded hands, compared to its average volume of 11,174,882. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The firm’s fifty day moving average price is $59.66 and its two-hundred day moving average price is $59.62. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $70.21 billion, a price-to-earnings ratio of 9.93, a price-to-earnings-growth ratio of 0.83 and a beta of 0.54.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. The firm had revenue of $91.23 billion for the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the prior year, the firm posted $2.21 earnings per share. On average, equities analysts expect that CVS Health Co. will post 6.41 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a $0.665 dividend. The ex-dividend date was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.77%. CVS Health’s dividend payout ratio is currently 47.33%.

Analysts Set New Price Targets

CVS has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft dropped their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Evercore ISI boosted their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Wells Fargo & Company lifted their target price on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. Mizuho reduced their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Finally, TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $59.00 to $85.00 in a report on Friday, October 4th. Nine analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $74.58.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.